How long can you live with breast carcinoma in situ

When talking about breast cancer, most women will feel scared because breast cancer is a cancer disease that can cause great harm to women's bodies. More importantly, breast cancer also has a high mortality rate. There are many types of breast cancer, among which carcinoma in situ of the breast is a more common type. If a patient is diagnosed with breast carcinoma in situ, how long can she expect to live?

The latest data show that the 10-year mortality rate of ductal carcinoma in situ of the breast is only 1.1%, and the 20-year mortality rate is only 3.3%. That is to say, out of 100 patients with breast ductal carcinoma in situ, 97 of them can basically be completely cured through current treatment.

Moreover, the chance of distant metastasis of carcinoma in situ is very small, only 1%. In contrast, the risk of recurrence and metastasis of invasive cancer is much higher, and it is an important cause of death in breast cancer patients.

However, based on the nuclear grade of the cancer cells, ductal carcinoma in situ can also be divided into low-risk, intermediate-risk and high-risk types. The risk of recurrence and metastasis of high-risk carcinoma in situ is much higher than that of medium- and low-risk ones.

Even so, the prognosis for high-risk DIS remains good with treatment.

As for low-risk carcinoma in situ, if the patients are older and more resistant to surgery or medication, they may not even have to pay attention to it and just observe it for a long time and follow up regularly.

Therefore, if you are unfortunately diagnosed with ductal carcinoma in situ, there is no need to be nervous, because its prognosis is very good and it will not affect your life expectancy in most cases. You just need to communicate well with your doctor and work together to develop a treatment plan that suits you.

Finally, the editor would like to remind you that even if the carcinoma in situ is cured, you should return to the hospital for regular follow-up throughout your life, because the chance of breast cancer developing on the opposite side of the carcinoma in situ is very high, 1.8 times higher than that of the normal population.

Treatment of breast carcinoma in situ

Treatment of breast carcinoma in situ: Breast carcinoma in situ includes lobular carcinoma in situ, ductal carcinoma in situ and Paget's disease of the nipple. Breast carcinoma in situ is a neoplastic lesion that is confined to the mammary ductal lobules and has the potential to develop into invasive cancer. Paget's disease of the nipple is mainly manifested by eczematous changes such as desquamation and erosion of the nipple epithelium, exudation, itching and crusting.

For the treatment of breast carcinoma in situ, the most important thing is comprehensive treatment based on surgical treatment. Once breast carcinoma in situ is diagnosed, you can choose to undergo mastectomy or breast-conserving surgery. In addition, the results of immunohistochemistry were followed after surgery. If the cancer is hormone receptor positive, endocrine therapy can be considered to prevent breast cancer in the contralateral breast. For patients who undergo breast-conserving surgery, it may have a certain effect in preventing the recurrence of ipsilateral breast cancer. Of course, for patients with breast carcinoma in situ, radiotherapy is necessary if breast-conserving surgery is performed. Its purpose is to prevent local recurrence of breast carcinoma in situ or development into invasive breast cancer.